Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01297985 · ClinicalTrials.gov registry record · NA

A Randomized Controlled Trial of Mental Health Peer-Led Education

A NA study of Mental Disorders, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
428
Enrollment target
1
Study location

NCT01297985: Completed NA study of Mental Disorders, sponsored by University of Illinois at Chicago.

NCT01297985 is a NA study of Mental Disorders that has completed, run by University of Illinois at Chicago. The registered enrollment target is 428 participants, below the 668-participant average among 25 other Mental Disorders trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01297985, a NA study of Mental Disorders, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
428 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial tests the efficacy of a mental health peer-led educational intervention called BRIDGES (Building Recovery of Individual Dreams and Goals through Education and Support). The BRIDGES program is a 10-week, manualized education course designed to provide basic information about the etiology and treatment of mental illness, self-help skills, and recovery principles in order to empower participants to return to valued social roles within their communities. BRIDGES is a peer-led program and all instructors are adults with mental illnesses. For study purposes, the 10-week course was modified to 8-weeks, meeting 2 1/2 hours once a week. Hypothesis #1: Compared to wait-list controls, intervention participants will report increased feelings of psychological empowerment. Hypothesis #2: Compared to wait-list controls, intervention participants will report increased feelings of hopefulness. Hypothesis #3: Compared to wait-list controls, intervention participants will report enhanced coping ability. Hypothesis #4: Compared to wait-list controls, intervention participants will report enhanced recovery. Hypothesis #5: Compared to wait-list controls, intervention participants will report greater ability to advocate for themselves with health care providers. Hypothesis #6: Compared to wait-list controls, those in the BRIDGES education course will report increased knowledge of the causes and treatment of mental illness and recovery principles.

Primary Outcome

Recovery from mental illness is measured by the Recovery Assessment Scale (RAS) (Giffort et al., 1995). Recovery is a psychosocial outcome assessed via patient self-ratings on a 41-item scale using a 5-point Likert-response format ranging from "strongly disagree" to "strongly agree." The minimum value for the RAS is 41 and the maximum is 205, with higher scores indicating a better outcome. Dimensions of recovery include personal confidence and hope, willingness to ask for help, goal and success

Conditions Studied

Interventions

  • BEHAVIORAL BRIDGES Peer-Led Education

Study Locations (1)

Tennessee

  • National Alliance on Mental Illness Tennessee - Nashville

Trial Details

FieldValue
Enrollment Target 428 participants
Start Date 2006-01
Est. Completion 2010-02
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT01297985 record still lists

NCT01297985 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 668-participant average among 25 other Mental Disorders trials with a reported enrollment target (36% lower).

The record links to 1 condition, with Mental Disorders appearing as the primary indexed condition, and to 1 intervention - of which BRIDGES Peer-Led Education is the first listed.

NCT01297985 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT01297985 about?

NCT01297985 is a clinical study titled "A Randomized Controlled Trial of Mental Health Peer-Led Education". This randomized controlled trial tests the efficacy of a mental health peer-led educational intervention called BRIDGES (Building Recovery of Individual Dreams and Goals through Education and Support). The BRIDGES program is a 10-week, manualized education course designed to provide basic informatio...

What is the current status of trial NCT01297985?

This trial is currently completed. It is a NA study. The enrollment target is 428 participants. The study started on 2006-01. Estimated completion is 2010-02.

What conditions does trial NCT01297985 study?

This clinical trial studies the following conditions: Mental Disorders.

What interventions are being tested in trial NCT01297985?

The interventions under investigation include: BRIDGES Peer-Led Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01297985?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01297985 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01297985's enrollment target sits among peer trials

428 7th of 25 higher than 19 of 25 other Mental Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05566431 · 428 participants · NA

    Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

  • NCT05646316 · 428 participants · Phase 3

    Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

  • NCT05797610 · 428 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

  • NCT06073626 · 428 participants · NA

    Addressing Genomic Disparities in Cancer Survivors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01297985, the US trial registry maintained by the National Library of Medicine. NCT01297985 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.